Memantine Therapy in Amyotrophic Lateral Sclerosis

NCT01020331 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Amyotrophic Lateral Sclerosis

Interventions

DRUG: Memantine

Sponsor

Phoenix Neurological Associates, LTD

Collaborators

[object Object]